Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study.
Masini C, Iotti C, De Giorgi U, Bellia RS, Buti S, Salaroli F, Zampiva I, Mazzarotto R, Mucciarini C, Vitale MG, Bruni A, Lohr F, Procopio G, Caffo O, Nole F, Morelli F, Baier S, Buttigliero C, Ciammella P, Timon G, Fantinel E, Carlinfante G, Berselli A, Pinto C. Masini C, et al. Among authors: mazzarotto r. Eur Urol. 2022 Mar;81(3):274-282. doi: 10.1016/j.eururo.2021.09.016. Epub 2021 Oct 1. Eur Urol. 2022. PMID: 34602312 Clinical Trial.
The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer.
Iacovelli R, Ciccarese C, Bria E, Romano M, Fantinel E, Bimbatti D, Muraglia A, Porcaro AB, Siracusano S, Brunelli M, Mazzarotto R, Artibani W, Tortora G. Iacovelli R, et al. Among authors: mazzarotto r. Clin Genitourin Cancer. 2018 Jun;16(3):e645-e653. doi: 10.1016/j.clgc.2017.12.007. Epub 2017 Dec 27. Clin Genitourin Cancer. 2018. PMID: 29339044
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma.
Bimbatti D, Ciccarese C, Fantinel E, Sava T, Massari F, Bisogno I, Romano M, Porcaro A, Brunelli M, Martignoni G, Mazzarotto R, Artibani W, Tortora G, Iacovelli R. Bimbatti D, et al. Among authors: mazzarotto r. Urol Oncol. 2018 Dec;36(12):526.e13-526.e18. doi: 10.1016/j.urolonc.2018.08.018. Epub 2018 Oct 6. Urol Oncol. 2018. PMID: 30301699
Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1).
Arcelli A, Buwenge M, Macchia G, Bertini F, Guido A, Deodato F, Cilla S, Scotti V, Rosetto ME, Djan I, Parisi S, Mattiucci GC, Cellini F, Fiore M, Bonomo P, Belgioia L, Niespolo RM, Gabriele P, Di Marco M, Simoni N, Mazzarotto R, Morganti AG; AIRO (Italian Association of Radiation Oncology and Clinical Oncology) Gastrointestinal Study Group. Arcelli A, et al. Among authors: mazzarotto r. Cancer Med. 2020 Nov;9(21):7879-7887. doi: 10.1002/cam4.3330. Epub 2020 Sep 10. Cancer Med. 2020. PMID: 32910549 Free PMC article.
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
Salvagno L, Sorarù M, Sotti G, Aversa S, Chiarion Sileni V, Mazzarotto R, Scarzello G, Bianco A, Pappagallo GL, Fiorentino MV. Salvagno L, et al. Among authors: mazzarotto r. Ann Oncol. 1995 Feb;6(2):173-9. doi: 10.1093/oxfordjournals.annonc.a059113. Ann Oncol. 1995. PMID: 7540419 Free article.
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma.
Simoni N, Micera R, Paiella S, Guariglia S, Zivelonghi E, Malleo G, Rossi G, Addari L, Giuliani T, Pollini T, Cavedon C, Salvia R, Milella M, Bassi C, Mazzarotto R. Simoni N, et al. Among authors: mazzarotto r. Clin Oncol (R Coll Radiol). 2021 Jan;33(1):e31-e38. doi: 10.1016/j.clon.2020.06.019. Epub 2020 Jul 15. Clin Oncol (R Coll Radiol). 2021. PMID: 32682686
70 results